Clinical Trial Update: GSK BHR Study (Sont - Second Study) [Phase 4]

View source ↗

Summary

This document reports the completion of GlaxoSmithKline's BHR Study (Sont - Second Study) in Phase 4 for asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED